Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
Want to see IN:NATHBIOGEN full AI Analyst Report?
Total Valuation
Nath Bio-Genes (India) Ltd. has a market cap or net worth of ₹3.26B. The enterprise value is ₹3.91B.
Market Cap₹3.26B
Enterprise Value₹3.91B
Share Statistics
Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,004,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nath Bio-Genes (India) Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.29%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.29%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee10.52M
Profits Per Employee984.17K
Employee Count423
Asset Turnover0.41
Inventory Turnover0.54
Valuation Ratios
The current PE Ratio of Nath Bio-Genes (India) Ltd. is ―. Nath Bio-Genes (India) Ltd.’s PEG ratio is 1.86.
PE Ratio―
PS Ratio0.58
PB Ratio0.38
Price to Fair Value0.38
Price to FCF-10.22
Price to Operating Cash Flow-0.02
PEG Ratio1.86
Income Statement
In the last 12 months, Nath Bio-Genes (India) Ltd. had revenue of 4.45B and earned 416.30M in profits. Earnings per share was 20.98.
Revenue4.45B
Gross Profit2.04B
Operating Income484.75M
Pretax Income463.04M
Net Income416.30M
EBITDA524.39M
Earnings Per Share (EPS)20.98
Cash Flow
In the last 12 months, operating cash flow was -1.09B and capital expenditures -11.04M, giving a free cash flow of -1.10B billion.
Operating Cash Flow-1.09B
Free Cash Flow-1.10B
Free Cash Flow per Share-57.77
Dividends & Yields
Nath Bio-Genes (India) Ltd. pays an annual dividend of ₹2, resulting in a dividend yield of 1.26%
Dividend Per Share₹2
Dividend Yield1.26%
Payout Ratio8.71%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.18
52-Week Price Change-10.84%
50-Day Moving Average157.85
200-Day Moving Average160.38
Relative Strength Index (RSI)55.89
Average Volume (3m)2.58K
Important Dates
Nath Bio-Genes (India) Ltd. upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 4, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Nath Bio-Genes (India) Ltd. as a current ratio of 1.97, with Debt / Equity ratio of 20.35%
Current Ratio1.97
Quick Ratio0.83
Debt to Market Cap0.54
Net Debt to EBITDA1.19
Interest Coverage Ratio3.03
Taxes
In the past 12 months, Nath Bio-Genes (India) Ltd. has paid 46.73M in taxes.
Income Tax46.73M
Effective Tax Rate0.10
Enterprise Valuation
Nath Bio-Genes (India) Ltd. EV to EBITDA ratio is 6.07, with an EV/FCF ratio of -12.72.
EV to Sales0.72
EV to EBITDA6.07
EV to Free Cash Flow-12.72
EV to Operating Cash Flow-14.46
Balance Sheet
Nath Bio-Genes (India) Ltd. has ₹1.59B in cash and marketable securities with ₹1.55B in debt, giving a net cash position of ₹40.40M billion.
Cash & Marketable Securities₹1.59B
Total Debt₹1.55B
Net Cash₹40.40M
Net Cash Per Share₹2.13
Tangible Book Value Per Share₹340.11
Margins
Gross margin is 45.80%, with operating margin of 10.89%, and net profit margin of 9.35%.
Gross Margin45.80%
Operating Margin10.89%
Pretax Margin10.40%
Net Profit Margin9.35%
EBITDA Margin11.78%
EBIT Margin10.89%
Analyst Forecast
The average price target for Nath Bio-Genes (India) Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast21.98%
EPS Growth Forecast5.46%